Exercise-induced irisin ameliorates cognitive impairment following chronic cerebral hypoperfusion by suppressing neuroinflammation and hippocampal neuronal apoptosis

Weiping Xiao, Yibing Yang, Bai Lu, Peixuan Yang, Runze Li, Daizhi Yang, Fanying Li, Lingzhi Quan, Q Liang, Yan Yan, Tiewei Qi, Liang FengJournal of Neuroinflammation 2025 · DOI

TL;DR

Chronic cerebral hypoperfusion (CCH), a hallmark of vascular dementia, leads to cognitive decline and neuroinflammation. This study reveals that exercise-induced irisin can mitigate these effects by promoting autophagy and reducing neuronal damage, offering a potential therapeutic avenue for CCH-related cognitive impairments.

What Problem Does This Paper Address?

Vascular dementia (VaD) is a major cause of cognitive decline, often stemming from chronic cerebral hypoperfusion (CCH). CCH damages the brain, leading to impaired cognitive function, neuroinflammation, and neuronal death. While exercise is known to benefit brain health, the specific mechanisms by which it might counteract CCH-induced damage, particularly through the hormone irisin, were not fully understood. This paper investigates how increasing irisin levels through exercise can protect against CCH-induced brain injury, focusing on its role in neuroinflammation and neuronal apoptosis.

Methods

The researchers utilized a mouse model of chronic cerebral hypoperfusion induced by bilateral common carotid artery stenosis (BCAS). They employed forced aerobic exercise (FAE), specifically swimming, to increase endogenous irisin levels. To investigate the role of irisin's receptor, they used cilengitide trifluoroacetate (CT), an integrin αVβ5 inhibitor. Key techniques included:

  • ELISA and Western Blotting: To quantify irisin, its precursor (FNDC5), and its receptors (integrin αV and β5) in serum and brain tissue. They also assessed protein levels related to apoptosis (caspase-3, Bcl-2, Bax, Bcl-XL), neuroinflammation (iNOS, CD86, TNFα), and autophagy (Beclin 1, SQSTM1, LC3B).
  • Immunofluorescence Staining: To visualize the localization of irisin receptors in neurons, microglia, and astrocytes, and to assess neuronal survival (NeuN), white matter integrity (MBP), and neuroinflammation (CD16, Iba-1, C3d, GFAP).
  • TUNEL Staining: To detect apoptotic neurons.
  • Neurobehavioral Tests: A battery of tests including the Novel Object Recognition Test (NORT), Y-maze test (YMT), Open Field Test (OFT), Elevated Plus Maze Test (EPMT), and Tail Suspension Test (TST) were used to evaluate cognitive function, anxiety, and depression-like behaviors.
  • Statistical Analysis: Standard statistical methods like Student's t-tests and one-way ANOVA with post-hoc tests were used to analyze the data. Pearson correlation analysis was employed to assess relationships between serum irisin levels and behavioral outcomes.

Datasets

Not discussed in the paper. The study relies on experimental data generated from mouse models.

Key Insights and Ideas

  • Irisin as a Brain-Muscle Communicator in CCH: The study strongly suggests that irisin acts as a crucial signaling molecule between skeletal muscle and the brain, particularly in the context of CCH. Exercise boosts irisin, which then travels to the brain to exert protective effects.
  • Integrin αVβ5 as the Key Receptor: The findings highlight integrin αVβ5 as the primary receptor for irisin in the brain, mediating its beneficial effects. Blocking this receptor with CT significantly diminished the positive outcomes of exercise.
  • Autophagy as a Central Mechanism: Irisin's neuroprotective effects are largely attributed to its ability to promote autophagy, a cellular "clean-up" process. This enhanced autophagy helps clear damaged components and reduces neuronal and microglial stress.
  • AMPK/mTOR Pathway Activation: The study elucidates that irisin, via integrin αVβ5, activates the AMPK pathway while suppressing mTOR. This balance is critical for promoting autophagy and cellular health.
  • Targeted Neuroinflammation Reduction: While CCH triggers neuroinflammation involving both microglia and astrocytes, FAE primarily attenuated microglial activation, suggesting a specific therapeutic target.

Key Results

  • CCH Decreases Irisin: Mice with CCH showed significantly reduced levels of irisin in both serum and the hippocampus, with a noticeable decrease in its precursor (FNDC5) and receptors (integrin αV and β5) in the hippocampus.
  • FAE Restores Irisin and Improves Cognition: Forced aerobic exercise (FAE) effectively increased both serum and hippocampal irisin levels. This led to significant improvements in cognitive functions (recognition memory, short-term memory) and a reduction in anxiety- and depression-like behaviors in CCH mice.
  • FAE Mitigates Neuronal Apoptosis and White Matter Injury: FAE treatment reduced hippocampal neuronal apoptosis (indicated by decreased cleaved caspase-3 and increased Bcl-XL) and improved white matter integrity (indicated by increased MBP intensity in the cortex).
  • FAE Suppresses Neuroinflammation: FAE significantly reduced pro-inflammatory markers in microglia (iNOS, CD86, TNFα) in the hippocampus and cortex of CCH mice.
  • CT Blocks FAE Benefits: Administration of the integrin αVβ5 inhibitor (CT) abolished the beneficial effects of FAE on cognitive function, anxiety, depression, neuronal apoptosis, and neuroinflammation, confirming the role of the irisin-integrin αVβ5 pathway.
  • FAE Enhances Autophagy: FAE treatment promoted autophagy in neurons and microglia, evidenced by increased Beclin 1 and LC3B-II levels, and reduced SQSTM1.

Limitations and Future Work

  • Irisin Normalization: The study notes that the exact increase in irisin levels for each mouse could not be normalized, which could be a factor in future research.
  • Pharmacokinetic Properties: The pharmacokinetic properties of irisin, including its half-life, are not fully elucidated and warrant further investigation.
  • Specific Autophagy Stages: The precise stage of the autophagic flux affected by irisin, and the specific types of selective autophagy involved (mitophagy, reticulophagy, lysophagy), require further exploration.
  • Sex Differences: The study exclusively used male mice. Future research should investigate sex differences and the potential impact of the estrous cycle.
  • Aged Models: The authors suggest that future studies should involve aged mice or rats, as CCH predominantly affects the elderly, and also include reproductively senescent females.
  • Translational Applicability: While promising, further research is needed to translate these findings to human patients, particularly in developing personalized exercise training programs.

Summary updated

Abstract

Our findings demonstrate that enhancing endogenous irisin via FAE mitigates CCH-induced neuronal apoptosis, microglial activation, cognitive impairment, and affective behavioral deficits by promoting autophagy through the integrin αVβ5/AMPK/mTOR signaling pathway.
BibTeX
@article{xiao2025exercise,
  author = {Weiping Xiao and Yibing Yang and Bai Lu and Peixuan Yang and Runze Li and Daizhi Yang and Fanying Li and Lingzhi Quan and Q Liang and Yan Yan and Tiewei Qi and Liang Feng},
  title = {{Exercise-induced irisin ameliorates cognitive impairment following chronic cerebral hypoperfusion by suppressing neuroinflammation and hippocampal neuronal apoptosis}},
  journal = {Journal of Neuroinflammation},
  year = {2025},
  doi = {10.1186/s12974-025-03493-5},
}
Figure